A very recent in vitro study offered further evidence indicating a protective role of HIF-1α versus lipid accumulation, which was attributed to its ability to activate the PPAR-α/ANGPTL4 signaling pathway in NAFLD [112]. This evidence concerns the gene HIF1A and metabolic dysfunction-associated steatotic liver disease.